Published in BMC Infect Dis on October 28, 2016
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol (2004) 4.90
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS (2010) 4.41
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis (2014) 3.09
Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol (2009) 2.34
Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord (2006) 2.26
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis (2011) 1.54
Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol (1996) 1.46
The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol (2005) 1.26
Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS One (2013) 1.11
Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology (2003) 1.05
Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement (2012) 1.00
Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry (2014) 0.97
Multivariate normative comparisons. Neuropsychologia (2007) 0.96
Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS (2015) 0.96
Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav (2011) 0.96
Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women. J Int Neuropsychol Soc (2013) 0.95
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology (2012) 0.91
Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Res Hum Retroviruses (2009) 0.90
Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol (1991) 0.90
Measuring the mind: assessing cognitive change in clinical drug trials. Expert Rev Clin Pharmacol (2008) 0.88
The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale. AIDS (2002) 0.88
Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. J Acquir Immune Defic Syndr (2014) 0.87
Exercise, sedentary pastimes, and cognitive performance in healthy older adults. Am J Alzheimers Dis Other Demen (2014) 0.82
Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals. Curr HIV/AIDS Rep (2016) 0.82
Understanding HIV-positive patients' preferences for healthcare services: a protocol for a discrete choice experiment. BMJ Open (2016) 0.79
Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers. J Infect Dis (2017) 0.75